-+ 0.00%
-+ 0.00%
-+ 0.00%

Neumora Therapeutics Announces 2026 Pipeline Strategy Including KOASTAL-2 and -3 Joint Readout, Initiation of NMRA-215 Obesity Clinical Program, and Advancement of NMRA-511

Reuters·01/05/2026 11:35:11

Please log in to view news